CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, InVivo’s Chief Executive Officer, is scheduled to present to investors at the 16th Annual Rodman & Renshaw Healthcare Conference to be held September 8-10, 2014 at the New York Palace Hotel in New York City. The presentation is scheduled for Wednesday, September 10th at 9:10AM ET. A live webcast will be available at http://wsw.com/webcast/rrshq24/nviv.
Additional information about the conference can be found at http://www.rodm.com/
InVivo will also be participating in the First Annual Zacks Healthcare Meetup on Monday, September 8th.
Mark Perrin said, “These meetings represent great opportunities for InVivo to update loyal investors and attract new investors alike. Both meetings are important components of a concerted effort to increase interaction with the investment community. I am excited to tell the story of the new InVivo and our efforts to develop effective therapies for spinal cord injury.”
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. In 2011 the Company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. The publicly traded company is headquartered in Cambridge, MA. For more details, visit, www.invivotherapeutics.com.